The positive was not notified, and this nucleic acid testing agency was investigated!He has been notified many times and has always wanted to go public!

Source: E Company ID: lianhuacaijing

Recently, the country has conducted special investigations on a large -scale nucleic acid testing agency, and many unqualified institutions have been gradually "excavated". A test agency in Shijiazhuang, Hebei boarded hot search because it was investigated without reporting a positive case.

A company reporter found that the group company behind the testing agency has repeatedly impacted the listing, but the four -time replacement of listed counseling agencies has been terminated in cooperation. From the perspective of public information, the company's management is chaotic, involving multiple lawsuits, and its company has previously fallen into a "false positive" controversy, and the inspection institute has also been ordered to rectify.

Positive unintentional reporting

According to a Weibo released by the "Shijiazhuang Public Security Network spokesman", on September 24, given the recent continuous epidemic situation in Yuhua District and the source is unknown. Inspection and inspection.

During the inspection, it was found that the "Shijiazhuang Hehe Medicine Inspection Lab" on September 14 was not reported to the one -tube 20: 1 mixed pipe positive sample of the Nucleic acid 361 community in Yuhua District. Community communication appeared on the 21st. The laboratory was suspected of illegal crimes, and the Shijiazhuang police had filed a case for investigation.

According to the company's inspection information, Shijiazhuang Hehe Medical Inspection Laboratory Co., Ltd. was established in November 2021, with a registered capital of 20 million yuan and a practical capital of 5.82 million yuan. "Hehe Diagnosis") wholly -owned subsidiary.

It is worth noting that Hefei Hefei Medical Inspection Laboratory, a subsidiary of Hehe, has fallen into a "false positive" controversy.

On April 23, the Hefei outbreak prevention and control emergency command reported that the two nucleic acid test laboratories including Hefei and Hehe Medicine were warned and cooperated to suspend the cooperation, saying that its superpowers contracting the testing business and seriously exceeded the promise time to issue testing The report has previously occurred in similar situations, and some also issued a "false positive" report several times, which seriously interfered with the overall situation of Hefei epidemic prevention and control.

In July, in the list of "Public Investigation Results of the Liaoning Provincial New Crown Virus nucleic acid testing institution" issued by the Liaoning Provincial Health and Health Commission, Shenyang Hehe Medical Inspection Institute, a wholly -owned subsidiary diagnosed by Hehe, was ordered to rectify.

Non -list

The reporter of E company noticed that Heheqin has not been available many times.

According to the official website of the Hehe Diagnosis, Hehe Diagnosis was established in December 2010. It is a national high -tech enterprise and is committed to providing third -party medical testing services for major hospitals across the country. At present, there are 21 scholars and branches in the country, with more than 200 sets of world -leading laboratory testing equipment, with a total of more than 10 million people, providing differences in more than 2,000 nationwide secondary levels, 500 or more three -level medical institutions. Chemical testing service.

After 7 years of establishment, the Hehe diagnosis tried to sprint the IPO, but it has been in the listed counseling stage from 2017 to 2021. Although the listing counseling agencies have been replaced four times, cooperation with Northeast Securities, West China Securities, Founder Securities, and Guohai Securities have been terminated. Although the planned listing sector was adjusted from the GEM to the science and technology board, it ended up.

The sprint IPO can't even pass the listing counseling, and the diagnosis is planned to be listed on the planning curve -backdoor ST nine. In 2021, ST Jiu announced that he intends to purchase shares and pay cash by issuing shares and payment of cash.

Two weeks after the suspension of trading, ST Jiu had a resumption of trading, indicating that the termination of major reorganizations was that "the number of shareholders of the target assets is large, the equity structure is scattered, and the respective interests of shareholders have different demands." ST Jiu said in a later explanation meeting that there were 97 shareholders diagnosed with Hexin.

The investigation information of the enterprise also shows that the Heping diagnosis involves multiple lawsuits. In addition to civil cases such as labor disputes and service contract disputes, there are many cases of defendant shareholders who harm the interests of the company's creditors and disputes in equity transfer disputes.

Editor -in -chief: Wang Lulu

School pair: Wang Jinsheng

- END -